Fixed Weight-Based Dosing of 3-Factor Pcc for Warfarin Reversal in Ich Is Safe and Efficacious

被引:0
|
作者
Mohrien, Kerry
Boucher, Andrew
Elijovich, Lucas
Jones, Morgan
机构
关键词
D O I
10.1097/01.ccm.0000439607.71143.bd
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
463
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Weight-based vs fixed dosing of darbepoetin alfa for anemia following kidney transplantation
    Solis, Jonathan
    Wilson, Nicole
    Sam, Teena
    Ma, Tsung-Wei
    Yango, Angelito
    Fischbach, Bernard
    Kataria, Ann D.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (21) : 1542 - 1549
  • [42] SAFETY and EFFECTIVENESS OF WEIGHT-BASED ACTIVATED PCC FOR WARFARIN-INDUCED LIFE-THREATENING BLEEDING
    Messana, Elizabeth
    Wilson, Suprat Saely
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [43] Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal
    Pansy Elsamadisi
    Mark A. G. Cepeda
    Tuyen Yankama
    Adrian Wong
    Qua Tran
    Ifeoma Mary Eche
    American Journal of Cardiovascular Drugs, 2021, 21 : 355 - 361
  • [44] Weight-Based Dosing Versus a Fixed-Dose Regimen of 4-Factor Prothrombin Complex Concentrate in Obese Patients Requiring Vitamin K Antagonist Reversal
    Elsamadisi, Pansy
    Cepeda, Mark A. G.
    Yankama, Tuyen
    Wong, Adrian
    Tran, Qua
    Eche, Ifeoma Mary
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2021, 21 (03) : 355 - 361
  • [45] COMPARISON OF FIXED VERSUS WEIGHT-BASED PROTHROMBIN COMPLEX CONCENTRATE DOSING IN CARDIAC SURGERY
    Peck, Marjorie
    Lanham, Kena
    Foster, Todd
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 55 - 55
  • [46] Weight-based thyroid dosing vs fixed dosing during pregnancy for subclinical hypothyroidism: A retrospective cohort study
    Bohlega, Balsam
    Zahedi, Afshan
    Tomlinson, George
    Feig, Denice S.
    CLINICAL ENDOCRINOLOGY, 2022, 96 (02) : 263 - 269
  • [47] Low-Dose 3-Factor Prothrombin Complex Concentrate for Warfarin Reversal Prior to Heart Transplant
    Kantorovich, Alexander
    Fink, Jodie M.
    Militello, Michael A.
    Wanek, Matthew R.
    Smedira, Nicholas G.
    Soltesz, Edward G.
    Moazami, Nader
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (08) : 876 - 882
  • [48] EMERGENT WARFARIN REVERSAL (EWR) COMPARING 3 COAGULATION FACTOR PRODUCTS: PCC3, PCC4, LDRFVIIA
    Chapman, Scott
    Rangarajan, Krishna
    Seaburg, Scott
    Abou-karam, Nada
    Rupnow, Nichole
    Beilman, Gregory
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [49] Systematic review: 3-factor versus 4-factor prothrombin complex concentrate for warfarin reversal: Does it matter?
    Voils, Stacy A.
    Baird, Brian
    THROMBOSIS RESEARCH, 2012, 130 (06) : 833 - 840
  • [50] IMPACT OF FIXED-DOSE 4F-PCC VERSUS WEIGHT-BASED 4F-PCC FOR FACTOR XA INHIBITOR MAJOR BLEEDING
    Ioppolo, Lacey
    Rottman, Kathleen
    Cannon, Chad
    Hayes, Sarah
    Allen, Bryan
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 159 - 159